| 摘要 |
<p>The invention relates, inter alia, to a method for reducing symptoms of, or for treating, one or more disorders or conditions wherein the dopaminergic system is disrupted, the method comprising administering to a host in need thereof an effective amount ofa compound that is able to increase the ion flow through KCNQ potassium channels.</p> |
